Innovent Dosed First Participant in Phase 3 Clinical Study (GLORY-2) of Mazdutide (IBI362) Higher Dose 9 mg in Chinese Adults with Obesity
ROCKVILLE, Md. and SUZHOU, China, Jan. 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and...
CGTN: Embracing 2024, how will China deliver a better life for the people?
BEIJING, Jan. 1, 2024 /PRNewswire/ -- China's ultimate goal is to deliver a better life for the people, Chinese President Xi Jinping said during his...
CGTN: How Chinese modernization brings new opportunities to world
BEIJING, Jan. 1, 2024 /PRNewswire/ -- The modernization of China has been an evolving pursuit of the Chinese people over generations. In 2023,...
Yunji Announces Appointment of New Independent Director
HANGZHOU, China, Jan. 1, 2024 /PRNewswire/ -- Yunji Inc. ("Yunji" or the "Company") (NASDAQ: YJ), a leading membership-based social e-commerce platform, today announced that...
Xi pledges to work with international society to build community with a shared future for mankind
BEIJING, Jan. 1, 2024 /PRNewswire/ -- A report from People's Daily: On New Year's Eve, Chinese President Xi Jinping delivered his 2024 New Year message...
LG Display Unveils Automotive Display Solutions Optimized for SDVs at CES 2024
SEOUL, South Korea, Jan. 1, 2024 /PRNewswire/ -- LG Display, the world's leading innovator of display technologies, announced today that it will unveil its...
